Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)

Historic Return on Invested Capital for Regenxbio (RGNX) over the last 4 years, with Q4 2022 value amounting to 0.49%.

  • Regenxbio's Return on Invested Capital fell 7200.0% to 0.49% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.49%, marking a year-over-year decrease of 7200.0%. This contributed to the annual value of 0.65% for FY2023, which is 2400.0% down from last year.
  • Latest data reveals that Regenxbio reported Return on Invested Capital of 0.49% as of Q4 2022, which was down 7200.0% from 0.15% recorded in Q3 2022.
  • Over the past 5 years, Regenxbio's Return on Invested Capital peaked at 0.24% during Q4 2021, and registered a low of 0.49% during Q4 2022.
  • For the 4-year period, Regenxbio's Return on Invested Capital averaged around 0.17%, with its median value being 0.25% (2020).
  • Over the last 5 years, Regenxbio's Return on Invested Capital had its largest YoY gain of 5900bps in 2022, and its largest YoY loss of -7200bps in 2022.
  • Quarter analysis of 4 years shows Regenxbio's Return on Invested Capital stood at 0.32% in 2019, then grew by 2bps to 0.31% in 2020, then skyrocketed by 177bps to 0.24% in 2021, then plummeted by -306bps to 0.49% in 2022.
  • Its Return on Invested Capital stands at 0.49% for Q4 2022, versus 0.15% for Q3 2022 and 0.16% for Q2 2022.